ArticleInflammatory bowel diseases2015

Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort.

Edward Shelton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.